Aehr Test Systems (AEHR) 2025 Deep Dive: AI Burn-In Orders, Q4 Numbers, $15.2M Backlog + Chart Setup (HTF/VCP)

Aehr Test Systems AEHR Stock Analysis 2025 is the key focus today, covering Q4/FY25 data, AI burn-in orders, backlog trends, and chart setups.

TL;DR

• Q4 FY25: Revenue $14.1M, GAAP EPS –$0.10, non-GAAP EPS –$0.01, bookings $11.1M, backlog $15.2M, cash $26.5M. FY25 revenue $59.0M.
• AI catalysts: Six “Sonoma” packaged-part burn-in (PPBI) systems ordered by a major hyperscaler; paid WLBI evaluation underway with a leading AI processor supplier.
• Chart setup: Monthly HTF-B, weekly VCP-B, daily VCP-C. Swing/medium-term setups look stronger than day-trading.

Why AEHR, Why Now? (AEHR Stock Analysis 2025 Context)

Institutions are already scanning for small-cap AI hardware enablers. AEHR sits in a unique spot: the tester and gatekeeper for both wafer-level (WLBI) and packaged-part (PPBI) burn-in.
The last 60 days delivered real, file-backed catalysts: new orders, a paid evaluation with an AI chip leader, and FY25 earnings. If funds are preparing for AI volume ramps, we should track the reliability bottleneck too.

For investors tracking AEHR Stock Analysis 2025, the institutional interest highlights a broader AI hardware shift.

Fresh Numbers: AEHR Stock Analysis 2025 First-Party Filings

• Q4 FY25 (ended May 31, 2025): Revenue $14.1M (vs. $16.6M YoY), GAAP EPS –$0.10, non-GAAP EPS –$0.01, bookings $11.1M, backlog $15.2M, cash $26.5M.
  These Q4 numbers form the backbone of AEHR Stock Analysis 2025, reflecting revenue momentum and backlog clarity.
• FY25 total: Revenue $59.0M, GAAP net loss –$3.9M, non-GAAP net income $4.6M.
• AI orders (Aug 25, 2025): Six Sonoma PPBI systems for AI processors, shipping across the next two quarters.
• AI WLBI evaluation (Aug 26, 2025): FOX-XP on 300 mm wafers, delivering hundreds of amps per device; timeline 3–6 months.

Chart Review (HTF/VCP Framework for AEHR Stock Analysis 2025)CP Framework)

Echo of Key Levels

• Close: $26.47
• Support/Resistance: $29.96 (target), $27.42 (pivot), $26.28 (intermediate), $25.08 (support), $23.95 (major support).
• Trend: Daily long-term moving averages are in bullish alignment. From a technical perspective, AEHR Stock Analysis 2025 shows both HTF and VCP setups forming across multiple timeframes.
• For comparison, see SiTime (SITM) 2025 Analysis which shows a similar MEMS timing setup.

Labels

• Monthly: HTF-B — powerful rebound, but no 20–25% tight flag yet; volume not confirming a textbook HTF-A.
• Weekly: VCP-B — 2nd contraction visible, but volume drying not yet clear (holding at average levels).
• Daily: VCP-C — lacks clear multi-step contraction; structure incomplete, but trend bias is positive with aligned MAs.

Trade Playbook for AEHR Stock Analysis 2025

A) Conservative Breakout

• Entry: Above $27.42 with volume confirmation + daily close
• Stop: $26.06
• Target: $29.96
• Risk/Reward: ~1:1.9

B) Flexible Swing

• Entry: Current zone ($26.47)
• Stop: $25.08
• Target: $29.96
• Risk/Reward: ~1:2.5

Re-entry trigger: If price retests $25.08 or touches the 5-day = 20-day “kiss” and then reverses upward.
Trend: Daily long-term moving averages are in bullish alignment. From a technical perspective, AEHR Stock Analysis 2025 shows both HTF and VCP setups forming across multiple timeframes.

Key Risks in AEHR Stock Analysis 2025

• Customer concentration: FY2024 10-K shows top 2 customers = ~84% of revenue. This makes quarterly results highly timing-sensitive.
• Evaluation uncertainty: WLBI pilot is not guaranteed to convert; delays or failure would reset expectations.

Action Steps

• Build your own catalyst tracker with three columns: (Date / What to confirm / Source link).
• Watch next 30–90 days:
  • Sonoma shipments (2 quarters).
  • WLBI evaluation results (3–6 months).
  • Backlog trend above $16M with higher AI mix.
• Comment below: Which metric should we chart first—backlog vs shipments, or WLBI vs PPBI economics?

Sources (First-Party Only)

• Aehr IR — Q4/FY25 press release (July 8, 2025)
• Aehr IR — Annual Reports & Proxy Statements
• SEC EDGAR — FY2024 10-K (customer concentration)
• Sonoma PPBI Hyperscaler Order (Aug 25, 2025) — Press release under verification, check Aehr IR Newsroom
• AI WLBI Evaluation (Aug 26, 2025) — Press release under verification, check Aehr IR Newsroom

Like This? 🚀

• Tap ♥️ Like if this saved you time.
• Subscribe to get the next deep dive (Part 3: GSIT).
• Comment with your ticker request—we’ll prioritize based on votes.

⚠️ Disclaimer

This article is for educational and informational purposes only and is not investment advice. Investing involves risk, including possible loss of principal. Always verify data with SEC filings and official IR releases, and consult a licensed advisor for personalized guidance. No compensation received from companies mentioned.

한국어 요약

• AEHR는 Q4/FY25 실적과 함께 하이퍼스케일러 PPBI 6대 주문 및 AI 프로세서 WLBI 유상 평가를 공시했습니다.
• 차트상 월봉 HTF-B / 주봉 VCP-B / 일봉 VCP-C로, 스윙·중기 전략이 단타보다 유리해 보입니다.
• 관전 포인트: $27.42 돌파 안착 또는 $25.08 리테스트 후 반등, 거래량 동반 확인이 관건입니다.
  👉 이번 Aehr Test Systems AEHR Stock Analysis 2025의 핵심은 실적, 신규 수주, 기술적 패턴을 종합적으로 확인하며 중장기 전략을 세우는 것입니다.